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Major depression is associated to altered hypothalamic-
pituitary function. Stress is linked to elevated cortisol as well as
menstrual cycle disturbance; however, there is no known relationship
between depression and menstrual cycle disruption. The aim of this
study was to investigate changes of growth hormone (GH) secretion






Patients and methods 
 
Nineteen women affected with depression
and 24 normal controls were included. The two groups had comparable













Nine depressed and 10 controls were studied in the follicular phase,
while 10 depressed and 14 controls were studied in the luteal phase
of the cycle. GH was sampled every 10 min for 24 h, and the data




There was no difference in 24-h mean GH concentrations
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 0·38). GH pulse frequency
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In studies of GH secretion in women with or without
depression, it is necessary to control for the phase of menstrual cycle.
(Received 12 January 2005; returned for revision 26 January 2005; 
 
finally revised 21 February 2005; accepted 9 March 2005)
Major depression is accompanied by abnormalities in multiple
endocrine systems. Depression alters pituitary function by increasing
the secretion of ACTH and cortisol. Whereas there is no known




stress, which is associated with elevated cortisol concentrations, is





of thyroid hormones, driven by another pituitary-regulated




While acute stress increases GH release, chronic stress is associated





endogenous cortisol excess, such as Cushing’s syndrome, are asso-









 However, it is not known whether depression,





alters GH concentrations. Previous studies on GH secretion




 did not take into









 The possibility of altered GH secretory
dynamics in depression is supported by reports that in affected
subjects, there is blunting of GH response to pharmacological





Growth hormone patterns of secretion in women are distinct from
that of male subjects. In women, growth hormone secretory patterns




 but whether GH varies




 We sought to determine
whether depression would be associated with a decrease in GH in
depressed premenopausal women recruited in both the follicular and






All participants were premenopausal women 20–50 years of age, who





from whom samples were still available. Depressed women were
recruited from patients presenting to the University of Michigan
Mood Disorders Program for treatment. We used an unselected
patient population, including patients with atypical depression
rather than restricting our population to melancholic depressed
women only. The original study from which this study represents
a subset, included 26 pairs of control and depressed women with













 We measured GH in 24 controls and 19 affected
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women. The difference in the size of the two groups was a result of
insufficient volume to perform GH in some depressed participants;
in addition, one subject with only 12-h sampling was eliminated
from the initial pool of subjects.
All studies were approved by the University of Michigan Insti-
tutional Review Board (IRB), and all participants gave written
informed consent. All subjects were otherwise healthy, and untreated
for the current episode at the time of the study except for one treat-
ment refractory depressed patient who was studied on antidepres-
sant therapy, and did not change the overall results. All others were
free of psychotropics and any other medications or hormonal con-
traception except for nonprescription pain medications, for more
than 3 months. Exclusion criteria also included shift work of travel
over more than (three) time zones within 3 months prior to enrol-
ment. The study was conducted in the General Clinical Research
Center (GCRC), where subjects were admitted for 26 h. A Structured
Clinical Interview for Diagnostic and Statistical Manual of Mental





structured Hamilton rating were conducted on all patients by our
research nurse to confirm the diagnosis. Normal controls had no pre-
vious psychiatric diagnosis as confirmed by Structured Clinical Inter-




 conducted by our research nurse.
They had no first degree relative with any Axis I disorder, and no
second degree relative with an anxiety or mood disorder as ascer-
tained by questioning the subject on all relatives. All subjects
underwent a screening physical exam, blood work and urine drug
screen. Controls were recruited to match depressed patients based
on age, BMI, menstrual cycle day and length. Each subject was
studied once in either the follicular or the luteal phase of the cycle.
The menstrual cycle phase was further confirmed with 24-h patterns






Subjects presented to the CRC at 8:00 h on day 1, when an
intravenous catheter was inserted. After a 60-min recovery period,
10-min sampling was initiated for 24 h. Normal saline was infused
throughout the study. While subjects were able to get up to go to
the bathroom, they remained at bed rest for the 24-h duration
of the study. Standardized meals were served at set times. Eating
between meals was not permitted, but decaffeinated beverages were
provided at set times. Subjects were free to turn off the lights at their
usual sleep times, but all lights were off by midnight. During over-
night sampling, blood was drawn with the aid of a flashlight, and
nurses recorded whether the subjects were awake or asleep with each













Plasma GH concentrations were measured using
a chemiluminescent enzyme immunometric assay for use with the
Immulite Automated Analyser (Immulite®, Diagnostic Product









assayed. Assay sensitivity was 0·01 ng/ml. The intra- and interassay
coefficients of variation (CV) were 2·0% and 4·5%, respectively.
Cortisol was assayed with a DPC Coat-a-count assay, a solid phase




g /dl. The intra-
and interassay coefficients of variation (CV) averaged 5·0% and 8%,
respectively.
 
Pulsatility and Statistical Analyses
 
Analysis of GH pulsatility was performed by Cluster Program








 statistic of 3 and 2 for
detecting significant increases and decreases in GH, respectively. The
mean pulse amplitude was calculated for each subject as the average
of the cluster-defined peaks. Pulse frequency is the number of pulses
detected by Cluster over a 24-h period. Twenty-four-hour mean GH
was calculated as the average of all GH values over the 24-h period.
Nocturnal GH was calculated as the average of plasma GH values
between 23:00 and 06:50 h.




 version 6·12 (SAS
Institute, Inc., Cary, NC). The differences in age and BMI among





relationships between the different parameters of the GH profiles to





/linear regression with forward selection.
Because of the effect of body weight on GH concentrations, all results
were adjusted for BMI, which was introduced in the model as a

















Patients’ descriptive and hormonal characteristics are shown





 0·14), and in the subjects studied during the follicular phase





Twenty-four–hour mean GH concentrations were not different




 0·93), and were not




 0·38). The intro-
duction of BMI as a covariate did not change these results. As






There was no difference in GH pulse frequency between depressed




 0·95). Pulse frequency was higher




 0·032), and this relation-




 0·46 for the interaction of
phase of menstrual cycle and depression state). Adjusting for BMI





Nocturnal GH was higher in the follicular phase of the cycle




 0·05) or whether total 24-h










for the interaction of phase of the menstrual cycle and state of
depression).
Representative GH profiles for each group are shown in Fig. 1.
Twenty-four–hour mean cortisol concentrations in women with




 0·97). It was also









Growth hormone secretion is sexually dimorphic. When women























 We studied 24-h GH patterns in 19 women affected





 and compared them to 24 normal
controls. Our findings indicate that 24-h GH secretion varies
throughout the menstrual cycle with higher pulse frequency and an
enhanced day-night variation during the follicular phase of the cycle.
This difference between the follicular and luteal phases of the cycle
was maintained regardless of depression.
Although GH-deficient states have been associated with depression,
there have been conflicting reports regarding altered GH secretion
in patients with established depression. Studies in women and late
adolescent females have been limited either by the lack of control


















 while others have found no differences between the




 Other studies have only
focused on differences of GH between the follicular and the peri-




 documenting a clear





GH response to pharmacological stimuli as an indirect mean for
assessing GH dynamics, rendering inferences to endogenous diurnal
rhythms difficult. Growth hormone concentrations are affected by




 It is also




 thus it is important to adjust
for BMI and age and/or account for them in the selection of parti-
cipants as was performed in our study.
Table 1. Hormonal and descriptive characteristics of depressed and control subjects recruited in the follicular and luteal phases of the menstrual cycle
 
Follicular Luteal 
Units Depressed Control Depressed Control
Age years 29·4 (9·8) 28·6 (9·7) 28·5 (7·4) 30·3 (7·4)
BMI kg/m2 24·9 (5·0) 24·5 (5·4) 27·1 (5·5) 23·5 (3·3)
Estradiol pmol/l 215·7 (128·3) 259·6 (168·6) 310·7 (231·1) 315·7 (164·8)
Progesterone nmol/l 1·5 (0·8) 1·6 (0·7) 17·6 (13·0) 14·7 (12·8)
24-h mean cortisol nmol/l 256·5 (111·5) 199·1 (36·5) 207·5 (34·7) 251·3 (115·8)
24-h mean GH ng/ml 2·6 (1·3) 2·8 (1·6) 2·4 (1·0) 2·9 (1·5)
Night GH* ng/ml 2·4 (1·6) 1·9 (1·1) 1·2 (0·6) 1·6 (0·8)
Total GH pulses** 8·9 (1·5) 9·7 (1·3) 8·8 (1·3) 8·3 (1·5)
Average GH pulse amplitude ng/ml 2·6 (1·1) 2·6 (1·4) 2·5 (1·4) 3·35 (2·1)
Average GH valley mean ng/ml 0·21 (0·16) 0·54 (0·51) 0·27 (0·07) 0·31 (0·23)
Significant difference between the follicular and the luteal phases of the menstrual cycle *P = 0·047.
Fig. 1 Representative 24-h GH profiles for the follicular and luteal phases of the menstrual cycle.
 














This is the first report on GH in women affected with depression
and compared to controls matched for the phase of the menstrual
cycle. As we have previously reported, depressed patients had




however, these depressed women did not demonstrate significantly
increased cortisol concentrations when compared to their normal
counterparts. In this study, depression had no significant impact
on GH concentrations in either follicular or luteal phases of the
menstrual cycle.
We used an unselected group of patients, including patients with
atypical depression, rather than restricting our study to melancholic
depressed women only. By recruiting unselected depressed women
presenting to the psychiatric clinic to seek treatment, we found
that only 19% of depressed women manifested increased baseline




g /dl). This is similar to the 7 of 32 (22%)






























 used dexamethasone nonsuppression to define sub-
groups, and found normal baseline cortisol in the dexamethasone
suppressors but significant increased cortisol secretion in dexame-
thasone nonsuppressors which were 15/40 (38%) patients in the









We did not use dexamethasone to select a subgroup, but overall our
data with women only agree with those studies including men and
older female subjects showing normal cortisol secretion in most
depressed subjects. Because of the quasi-normal cortisol level of our
participants, there is still a possibility that patients with severe
depression and markedly increased cortisol concentrations would
show differences in GH concentrations when compared to normal
subjects.
In summary, 24-h GH concentrations are maintained throughout
the menstrual cycle. However, there is increased pulse frequency as
well as enhanced nocturnal concentration in the follicular phase of
the cycle. Depression does not affect these changes. We conclude that
controlling for the menstrual cycle is needed in studies focused
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